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Abstract
Background and Aims Crohn’s disease (CD) is an inflammatory bowel disease (IBD) caused by a combination of genetic,
clinical, and environmental factors. Identification of CD patients at high risk of requiring surgery may assist clinicians to
decide on a top–down or step-up treatment approach.
Methods We conducted a retrospective case–control analysis of a population-based cohort of 503 CD patients. A regression-
based data reduction approach was used to systematically analyse 63 genomic, clinical and environmental factors for
association with IBD-related surgery as the primary outcome variable.
Results A multi-factor model was identified that yielded the highest predictive accuracy for need for surgery. The factors
included in the model were the NOD2 genotype (OR=1.607, P=2.3×10−5), having ever had perianal disease (OR=2.847,
P=4×10−6), being post-diagnosis smokers (OR=6.312, P=7.4×10−3), being an ex-smoker at diagnosis (OR=2.405,
P=1.1×10−3) and age (OR=1.012, P=4.4×10−3). Diagnostic testing for this multi-factor model produced an area under the
curve of 0.681 (P=1×10−4) and an odds ratio of 3.169, (95 % CI P=1×10−4) which was higher than any factor considered
independently.
Conclusions The results of this study require validation in other populations but represent a step forward in the development of
more accurate prognostic tests for clinicians to prescribe the most optimal treatment approach for complicated CD patients.
Keywords NOD2 genotype . Smoking . Perianal disease
Introduction
Crohn’s disease (CD) is believed to be a consequence of
multi-factorial interactions between genetic, immune-
related, environmental and microbial triggers that combine
to influence the clinical development and progression of this
disease.1 CD has a relapsing–remitting course and treatment
depends on controlling disease symptoms and maintaining
remission. However, a majority of CD patients require sur-
gery within the first 10 years of diagnosis.2 Current treat-
ment strategies include the top–down and the step-up ap-
proach, the former having evolved from the impact of anti-
tumour necrosis factor (anti-TNF) therapies.3 However,
there is currently no definitive clinical strategy for clinicians
to decide which treatment strategy should be used at diag-
nosis. CD encompasses a wide range of phenotypes and
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clinical outcomes that may be determined by the genetic
make-up or environmental exposures of an individual. The-
se characteristics and outcomes may inform the clinician as
to the therapeutic strategy to adopt, for example early ag-
gressive therapy for those patients who are most likely to
progress to surgery.2,3
A range of factors have been associated with an increased
risk of complicated (stricturing and penetrating) CD behav-
iour including the specific NOD2 genotypes4–6 having had
perianal disease8–11 and cigarette smoking.1,6,8,12–14 Com-
plicated disease is strongly associated with a requirement for
surgery15; therefore, knowledge of such genetic, environ-
mental and clinical predictors may guide clinicians in devel-
oping a personalised approach for individual patients.2,3,16
The ability to predict those who will have a more indolent
disease course is also important given the range of adverse
drug reactions and the cost of anti-TNF drugs.3,17
There is a lack of data concerning which patients would
benefit most from a top–down or bottom–up treatment strat-
egy. This highlights the need for better and more accurate
prognostic and diagnostic tests for predicting clinical out-
comes for CD patients.
This study aims to identify envirogenomic risk factors of the
need for surgery as a clinical outcome for CD patients from a
population based cohort. The use of any single causative risk
factor for diagnosing the development of complicated CD
forms is unreliable. Hence, it is expected that by combining
information from multiple environmental, clinical and genetic
factors, we will be able to develop more accurate personalised
profiles that can be used for the early treatment of CD patients.
Table 1 Genomic factor analysis model using unadjusted multiple logistic regression
CHR SNP Gene Minor/major
allele
MAF Genotype frequencies Genotypic Allelic
Case (n=174) Control (n=333) CHISQ P value CHISQ P value
1 rs11209026 IL23R A/G 0.030 0/10/155 0/25/287 – – 0.582 0.446
1 rs35829419 NALP3 A/C 0.045 0/15/153 1/21/305 1.531 0.465 0.539 0.462
2 rs2241880 ATG16L1 C/T 0.419 31/79/58 56/162/109 0.302 0.859 0.000 0.984
4 rs6822844 IL21 T/G 0.314 11/83/73 27/180/124 1.915 0.384 1.512 0.219
5 rs13361189 IRGM T/C 0.089 1/28/139 2/49/278 0.267 0.875 0.222 0.638
5 rs4958847 IRGM G/A 0.142 1/46/122 4/70/254 2.494 0.287 1.076 0.2995
16 NOD2a NOD2 T/A 0.347 18/77/68 16/128/168 9.360 0.009 8.510 0.004
19 rs2043211 CARD8 T/A 0.278 13/67/87 32/136/162 0.680 0.712 0.645 0.424
22 rs4821544 NCF4 T/C 0.333 22/66/77 28/120/167 3.013 0.222 3.016 0.082
a 702W, 908R, and 1007fs mutations
CHR chromosome, SNP single nucleotide polymorphism, MAF minor allele frequency, CHISQ Chi-square
Table 2 Genomic factor analysis model using adjusted step-wise for-
ward conditional logistic regression
Predictor B SE P value OR 95 % CI
Lower Upper
NOD2 0.471 0.196 0.016 1.601 1.091 2.348
B coefficient for the constant in the null model/intercept, SE standard
error, OR odds ratio, CI confidence interval)
Table 3 Disease history—clinical factor analysis
Predictor B SE P value OR 95 % CI
Lower Upper
Unadjusted multiple logistic regression model for disease history
clinical factors
Perianal disease 1.022 0.215 0.000 2.779 1.822 4.238
Depression 0.426 0.252 0.091 1.531 0.934 2.510
Asthma 0.033 0.233 0.886 1.034 0.655 1.631
Eczema 0.455 0.257 0.077 1.576 0.952 2.608
Glandular fever 0.269 0.286 0.346 1.309 0.747 2.293
Kidney stones 0.055 0.742 0.940 1.057 0.247 4.525
Liver disease 0.082 0.524 0.876 1.085 0.389 3.030
Mental illness 0.048 0.731 0.948 1.049 0.250 4.393
Bronchiectasis 0.150 1.470 0.919 1.161 0.065 20.708
Cancer 0.730 0.487 0.134 2.074 0.799 5.383
Tonsillectomy 0.060 0.224 0.790 1.061 0.685 1.645
Chole 0.032 0.408 0.938 1.032 0.464 2.296
Grommett 0.380 0.574 0.508 1.463 0.474 4.509
Adjusted step wise forward conditioning model for disease history
clinical factors
Perianal disease 0.991 0.211 0.000 2.695 1.783 4.074
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Materials and Methods
Patient Selection and Data Ascertainment
This study was a retrospective case control analysis of
existing data obtained from a population-based CD cohort.6
The selection of patients, their data collection, as well as
DNA extraction and genotyping was previously performed
as part of the Canterbury Inflammatory Bowel Disease (IBD)
Project.6,7 Briefly, all patients were diagnosed with CD and
phenotyped using the Montreal Classification System
(MCS).6,7 Clinical data were gathered for 715 CD patients
in the Canterbury IBD study. Genotype data were available
for 503 patients. Eight single nucleotide polymorphisms for
seven genes and three variants of the NOD2 gene were
genotyped for the 503 patient case studies with CD from
the Canterbury IBD cohort. Genotyped patients included 306
females and 197 males. These were the only genetic data
available from the original Canterbury IBD project. The
average age of the patients was 45 years, and the average
disease duration was 9 years (no subsequent follow-up date
was available at the time of analysis). Disease behaviour was
classified using the MCS, and 160 patients were diagnosed
with stricturing disease behaviour, 57 patients with penetrat-
ing and 286 patients with non-stricturing non-penetrating
disease behaviour. A total of 211 patients had colonic disease
location, 166 with ileal location and 126 with ileocolonic
disease location. A total of 63 variables including genetic,
environmental and clinical factors were analysed as part of
this study. Environmental data were collected using a self-
administered questionnaire.6 The primary outcome variable
Table 4 Medical treatment
history—clinical factor analysis
(unadjusted multiple logistic regres-
sion model for medical treatment
history clinical factors)
OCP oral contraceptive pill
Predictor B SE P value OR 95 % CI
Lower Upper
Ever used immunomodulaters 1.029 0.595 0.084 2.797 0.871 8.980
Immunised against measles 0.185 0.974 0.849 1.203 0.178 8.123
Immunised against mumps 1.332 0.926 0.150 3.787 0.617 23.233
Immunised against TB 1.151 0.707 0.104 3.163 0.791 12.649
Antibiotic consumption 0.062 0.852 0.942 1.063 0.200 5.644
Current OCP consumption 0.498 1.355 0.713 1.645 0.116 23.426
Ex OCP consumer 1.249 1.310 0.340 3.487 0.267 45.492
Antibiotic consumption during infancy 0.543 0.910 0.551 1.721 0.289 10.234
Antibiotic consumption during childhood 1.747 1.520 0.250 5.740 0.292 112.847
Antibiotic consumption during adolescence 2.532 1.756 0.149 12.577 0.402 393.102
Medication consumption during infancy 0.212 2.526 0.933 1.236 0.009 174.648
Medication consumption during childhood 2.128 2.224 0.339 8.400 0.107 657.071
Medication consumption during adolescence 0.655 1.064 0.538 1.925 0.239 15.505
Table 5 Smoking—environmental factor analysis
Predictor B SE P value OR 95 % CI
Lower Upper
Unadjusted logistic regression for smoking environmental factor analysis
Mother smoker 0.036 0.239 0.880 1.037 0.649 1.655
Ever smoker 0.222 0.235 0.346 1.248 0.787 1.980
Smoker at dx 1.539 0.684 0.024 4.661 1.220 17.809
Post-dx smoker 1.984 0.673 0.003 7.723 1.946 27.173
Never smoker 0.260 0.194 0.181 1.297 0.886 1.897
Ex-smoker at dx 2.677 0.704 0.000 14.536 3.660 57.731
Adjusted step wise forward conditioning logistic regression model for
smoking environmental factors
Post-dx smoker 1.679 0.668 0.012 5.359 1.448 19.834
Ex-smoker at dx 0.995 0.272 0.000 2.706 1.588 4.611
*dx diagnosis, post-dx post-diagnosis
Table 6 Diet—environmental factor analysis (unadjusted logistic regres-
sion model for diet environmental factors)
Predictor B SE P value OR 95 % CI
Lower Upper
Breastfed 0.104 0.218 0.634 1.109 0.724 1.700
Alcohol 0.128 0.211 0.546 1.136 0.751 1.719
Vegetarian 0.231 0.454 0.611 1.260 0.517 3.068
Takeaways infant 0.157 0.344 0.648 1.170 0.596 2.297
Takeaways child 0.036 0.283 0.899 1.037 0.595 1.805
Takeaways
adolescence
0.235 0.240 0.326 1.265 0.791 2.024
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was the need for any type of IBD-related surgery in CD
patients. This outcome variable was generalised to include
all types of IBD-related surgical resections as determined
from patient records by the lead investigative clinicians (RG
and MB) at the time of recruitment. Because this information
did not form a primary outcome in the main study, more
detailed data regarding the specific type, location and reason
for resection were not available. A total of 174 cases had at
least one IBD-related surgery within this cohort and 329 had
never had IBD-related surgery at the time of recruitment.
Statistical Analysis
In analysing the data, a step-wise data reduction approach was
used with the aim of identifying “envirogenomic” profiles that
predict risk of surgery in CD patients. Using a systematic
approach, the multiple clinical, genetic and environmental
factors were logically analysed and reduced down to signifi-
cantly associated factors using the need for surgical interven-
tion as the primary outcome variable. All significantly asso-
ciated factors from the genetic, clinical and environmental
data analysis were then combined to produce a significantly
associated single multi-factor model which identified the pa-
tient as being either at risk or with no risk for the need of
surgical intervention (Supplementary Fig. 1).
Genotype data were cleaned and sorted to create files
suitable for analysis in PLINK and SPSS, and disease
risk phenotype was incorporated into this file for further
analyses. These data were examined for any discrepan-
cies with original studies performed on the same cohort
and no differences were found. The systematic five-step
analysis strategy was performed as follows (see also
Supplementary Fig. 2).
Step one—using the software package PLINK, standard
case–control analyses were performed to test for association
between gene variants and the need for surgery as the clinical
outcome (model option). This identified the genetic factors
associated with the primary clinical outcome. Step two—using
SPSS, clinical factors were statistically analysed using
unadjusted multi-factor logistic regression models. All clinical
factors were divided into two variable subgroups: (1) disease
history and (2) medical treatment history. After a preliminary
model analysis, adjustments using forward conditioning were
performed as part of the logistic regression analysis and signif-
icant factors were entered into the model. Step three—all
environmental factors were divided into three groups of vari-
ables for this analysis: (1) smoking exposure, (2) diet and (3)
Table 7 Household—environm-
ental factor analysis (unadjusted
logistic regression for environ-
mental factors)
Predictor B SE P value OR 95 % CI
Lower Upper
Public swimming 0.059 0.170 0.730 1.061 0.760 1.480
Pool infant 0.576 0.355 0.104 1.778 0.888 3.564
Pool child 0.242 0.254 0.341 1.273 0.774 2.094
Pool adolescent 0.120 0.246 0.626 1.127 0.696 1.826
Sand pit infant 0.060 0.168 0.720 1.062 0.764 1.475
Sand pit child 0.023 0.176 0.895 1.024 0.725 1.446
Sand pit adolescent -0.412 0.231 0.074 0.663 0.422 1.041
Farm infant 0.113 0.206 0.583 1.120 0.748 1.676
Farm child 0.182 0.198 0.358 1.199 0.814 1.766
Farm adolescent 0.200 0.210 0.339 1.222 0.810 1.843
Smoke infant -0.321 0.171 0.060 0.725 0.519 1.014
Smoke child -0.233 0.166 0.161 0.792 0.572 1.097
Smoke adolescent -0.234 0.165 0.156 0.791 0.573 1.093
Share bedroom infant -0.096 0.166 0.564 0.909 0.656 1.258
Share bedroom child 0.053 0.164 0.748 1.054 0.764 1.454
Share bedroom adolescent 0.000 0.167 0.999 1.000 0.720 1.388
Table 8 Combined envirogenomic factor analysis (adjusted forward
logistic regression analysis using the multi-factor model)
Predictor B SE P value OR 95 % CI
Lower Upper
NOD2 0.469 0.207 0.024 1.599 1.065 2.400
Perianal disease 0.971 0.222 0.000 2.641 1.708 4.082
Ex-smoker at
diagnosis
0.782 0.263 0.003 2.187 1.307 3.659
Post-diagnosis
smoker
1.705 0.682 0.012 5.500 1.445 20.941
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household. SPSS was then used to perform an unadjusted
multiple logistic regression model. After the preliminary
model analysis, forward conditioning was performed by
using the subsequently analysed factors that were entered
into the model. Step four—this step involved a multi-factor
analysis, model, by taking all of the previously significantly
associated factors from all adjusted individual models that arose
from analysis in previous steps and entered into a forward
conditioned multiple logistic regression model collectively.
The multi-factor model was also adjusted for age and sex. Step
five—after identification of significantly associated predicting
factors of the need for surgery, stepwise statistical diagnostic
tests were performed to verify the predictive probability and
accuracy of the multi-factor envirogenomic risk profile model
(Supplementary Fig. 2).
Results
Step One: Genomic Factor Analysis PLINK analysis of the
gene variants considered separately revealed that the NOD2
genotype was the sole factor significantly associated with the
need for surgery in this CD patient cohort (Table 1). After
running binary logistic regression using stepwise forward
conditioning on all variants the NOD2 gene still remained
as the most significantly associated risk factor for need for
surgery in the cohort (OR=1.601, P=1.6×10−3) (Table 2).
Step Two: Clinical Factor Analysis The 26 clinical factors
were divided into two groups of variables: (1) disease history
and (2) medical treatment history. Disease history variables
included variables relating to the history of any type of
disease/illness for each patient. Medical treatment history
variables included variables relating to the patients history
of any type of medical treatment. Disease history—the
unadjusted logistic regression analysis model for the 13
factors within this group is shown in Table 3. Table 3 shows
the adjusted multiple forward conditioning logistic regres-
sion analytical model. The final model shows that after
stepwise data reduction analysis those patients who had ever
had perianal disease (OR=2.695, P=1×10−4) were more
likely to require surgery. Medical treatment history—the
unadjusted logistic regression analysis model for the 13
factors within this group is shown in Table 4. The final
adjusted step wise forward conditioning regression model
showed that there were no significantly associated variables
from this group of factors.
Step Three: Environmental Factor Analysis The 28 environ-
mental factors were divided into three groups of variables:
(1) smoking, (2) diet and (3) household. Smoking variables
included all variables related to smoking. Diet variables
included all variables relating to the patients diet. Household
variables included all variables relating to the patients house-
hold characteristics. Smoking—there were 6 factors that
were included in this group of variables that were analysed
using unadjusted logistic regression analysis (Table 5). In the
next step, step wise forward conditioning logistic regression
analysis was performed on these 6 factors and the model
(Table 5) shows that after the data reduction analysis those
patients who were post-diagnosis smokers (OR=5.359,
P=1.200×10−3) or ex-smokers at diagnosis (OR=2.706,
P=1×10−4) remain as significantly associated with the need
for surgery. Diet—this group of variables had 6 factors and
after unadjusted regression and a step wise forward condi-
tioning data reduction; no factors were seen as significantly
associated with the need for surgery (Table 6). Household—a
total of 16 factors were analysed within this group of vari-
ables. After unadjusted logistic regression models and adjust-
ed forward conditioning regression models were created no
factors showed any significant association with the need for
surgery (Table 7).
Table 9 Combined
envirogenomic factor analysis
(adjusted forward logistic re-
gression analysis using the multi-
factor model, adjusted for age
and gender)
Predictor B SE P value OR 95 % CI
Lower Upper
NOD2 0.474 0.208 0.023 1.607 1.068 2.417
Perianal disease 1.046 0.227 0.000 2.847 1.823 4.447
Ex-smoker at diagnosis 0.878 0.268 0.001 2.405 1.422 4.069
Post-diagnosis smoker 1.842 0.687 0.007 6.312 1.640 24.285
Current age 0.012 0.006 0.044 1.012 1.000 1.024
Fig. 1 Regression equation for the multi-factor envirogenomic model
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Step Four: Multi-factor Analysis After analysing all of the
genetic, clinical and environmental factors independently,
the next step involved taking all of the significantly associ-
ated variables from each of these three factor groups and
analysing them collectively. The factors NOD2 gene, perianal
disease, ex-smoker at diagnosis and post-diagnosis smoker
stood out as significant and all these factors underwent a
forward conditioning logistic regression multi-factor model
analysis (Table 8). The next step involved using our combined
multi-factor model and adjusting the results for age and gender.
The final, adjusted multi-factor model showed that current age
(OR=1.012, P=4.4×10−3) was significantly associated with the
need for surgery alongwith the four previously identified factors
which included the NOD2 gene (OR=1.607, P=2.3×10-5),
perianal disease (OR=2.847, P=4×10−6), ex-smoker at diag-
nosis (OR=2.405, P=1.1×10−3) and post-diagnosis smoker
(OR=6.312, P=7.4×10−3) (Table 9). In the final model,
age was also associated with the outcome (OR=1.012,
P=4.4×10−3). Figure 1 shows the final regression equation
that can be derived from the final multi-factor envirogenomic
model.
Step Five: Diagnostic Testing To test the predictive value of
the final combined model derived from the previous analyt-
ical steps, various investigative tests were performed on the
individual probabilities generated form the regression mod-
el. First, ROC curves displaying the AUC were created for
the combined multi-factor model as well as for models of the
clinical, environmental and genetic factors considered indi-
vidually (Fig. 2). For the individual factor, the genomic
model produced an AUC of 56 % (P=3.7×10−3), the clinical
model produced an AUC of 60 % (P=1×10−4) and environ-
mental model produced an AUC of 59 % (P=1×10−4).
When genomic and clinical factors are combined the AUC
slightly increases to 63 % (P=1×10−4) and when clinical and
environmental factors are combined the AUC also increases
slightly to 65 % (P=1×10−4). Whilst the individual factor
models offered some predictive value it was found that the
multi-factor envirogenomic model produced the highest pre-
dictive value of (AUC=0.68, P=1×10-4) (Table 10), and
hence this model was used for further diagnostic testing. In
order to dichotomise our curve, and hence stratify the pa-
tients into either a high risk or a low risk category, an optimal
cutoff point needed to be chosen. To do this, two points were
selected at 80 % sensitivity and 80 % 1-specificity (Fig. 3).
Diagnostic calculations were performed on both cutoff
points (Table 11), and it was found that the second cutoff
point at 80 % 1 (specificity) showed the higher odds ratio
(OR=3.169, P=1×10−4), higher positive predictive values
(0.545) and also had a higher attributable risk (0.271).
Discussion
Many studies have shown that besides genetic factors, clinical
and environmental factors are also explanatory components of
the pathogenesis of CD and are primarily responsible for its
Fig. 2 Area-under-the-curve analysis for the combined envirogenomicmodel
Table 10 ROC model factor ef-
fects on the AUC
ROC receiver operating charac-
teristic, AUC area under the
curve
Factors AUC SE P value 95 % CI
Lower Upper
Genomic 0.558 0.028 0.037 0.504 0.613
Clinical 0.603 0.028 0.000 0.548 0.659
Environmental 0.590 0.027 0.001 0.537 0.644
Genomic+clinical 0.630 0.028 0.000 0.576 0.684
Genomic+environmental 0.629 0.027 0.000 0.576 0.682
Clinical+environmental 0.654 0.026 0.000 0.604 0.705
Genomic+clinical+environmental 0.681 0.027 0.000 0.629 0.733
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growing incidence around the globe.6,7,17–19 The natural dis-
ease course for CD is highly variable among patients ranging
from mild cases requiring dietary modification to severe cases
requiring surgery. Therefore, clinicians need to be accurate in
their diagnosis and prediction of disease progression when
treating patients in order to personalise medical therapy and
optimise outcome. This involves not only assessing clinical
risk factors but also the growing number of genetic and
environmental risk factors associated with disease progression
and outcome. Early intervention and diagnosis is necessary for
patients so that optimal treatment can be achieved and pro-
gressive disease symptoms can be avoided. One goal of clini-
cians is to utilise predictive factors to accurately categorise
patients as either high or low risk for requiring surgery. Hence,
clinicians could use such algorithms to select the optimal
treatment approaches and deliver personalised medicine. This
could include top-down therapy for those with higher risk and
a more traditional approach for those with a lower risk of
requiring subsequent surgery.
Researchers to date have been able to identify individual
factors that are associated with increased risk of complicated
CD and risk IBD-related surgery, however utilising individual
risk factors for prognostic purposes has not been widely
used in practice because of the limited predictive accuracy
for any single risk factor. The multi-factor method applied
to this population-based IBD cohort has identified genetic,
clinical and environmental factors that can be combined to
predict the need for IBD-related surgery in CD patients.
The multi-factor envirogenomic model included NOD2 ge-
notype, perianal disease, and smoking and age factors and
yielded increased predictive value over each factor when
considered individually.
The NOD2 gene variants have been previously associated
with the risk of developing complicated CD.4–8,18 Smoking
has also been associated with the development and progression
of CD,6,8,12–14,18 increasing the risk for IBD-related surgery.
Similarly, perianal disease is associated with an increased risk
of progressive complicated CD8–11 and resectional surgery.
Others have also demonstrated the clinical utility of combin-
ing clinical, serological and genetic CD data to predict the
progression and severity of CD.20 We have also previously
shown that the risk of surgery is associated with combined
genetic and clinical factors—NOD2 genotype and perianal dis-
ease. However studies where clinical, genetic and environmental
data have been combined and analysed in a systematic way to
yield an envirogenomic profile for estimating the risk of com-
plicated disease and surgical intervention have not been
performed previously. Previous studies have also shown inde-
pendent predictor models for various individual risk factors14 as
well as formulated tools to predict the development of compli-
cated CD using independent risk factors17; however, the multi-
factor model developed in this study produces a much higher
predictive probability for the risk of surgery thenwhen any of the
risk factors are considered independently, indicating the useful-
ness of the method of research utilised in this study. Consequent-
ly, our multi-factor envirogenomic risk model has taken a step
closer to identifying patients at risk for the need of surgery
potentially allowing early and personalised therapeutic decisions
to be made that can prevent the development of complicated
disease.
From this study, it can be concluded that CD patients from
this New Zealand population who possess these clinical,
genetic and environmental disease factors are at higher risk
of IBD-related surgery. Further analyses of other large and
well-characterised cohorts, including prospective assessment,
may confirm these findings, and it is also possible that other
Table 11 Statistical diagnostic calculations on two selected cutoff points
OR P value Sensitivity Specificity PPV NPV Attributable risk RR
Cutoff 1 2.397 0.000 0.801 0.373 0.411 0.775 0.185 1.823
Cutoff 2 3.169 0.000 0.447 0.797 0.545 0.725 0.271 1.986
Cutoff 1=80 % (sensitivity); cutoff 2=80 % 1 (specificity)
PPV positive predictive values, NPV negative predictive values, RR relative risk
Fig. 3 Cutoff point selection and diagnostic risk division
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makers of disease severity and prognosis may be able to be
integrated into this model. This and related research highlights
the clinical usefulness of genomic, epidemiological and clin-
ical research in predicting outcomes for patients with CD.
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